5.875
전일 마감가:
$6.05
열려 있는:
$6.14
하루 거래량:
81,140
Relative Volume:
0.95
시가총액:
$59.16M
수익:
$442.00K
순이익/손실:
$-30.46M
주가수익비율:
-1.3173
EPS:
-4.46
순현금흐름:
$-27.47M
1주 성능:
-7.04%
1개월 성능:
+10.23%
6개월 성능:
+69.80%
1년 성능:
+26.07%
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
CLNN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CLNN
Clene Inc
|
5.875 | 60.92M | 442.00K | -30.46M | -27.47M | -4.46 |
![]()
JBS
Jbs N V
|
14.72 | 33.56B | 60.44B | 2.01B | -373.53M | 1.5518 |
![]()
KHC
Kraft Heinz Co
|
25.81 | 31.65B | 25.31B | -5.27B | 3.49B | -4.49 |
![]()
K
Kellanova
|
77.07 | 26.76B | 12.64B | 1.35B | 650.00M | 3.81 |
![]()
GIS
General Mills Inc
|
49.43 | 27.26B | 19.64B | 2.56B | 2.48B | 4.55 |
![]()
MKC
Mccormick Co Inc
|
64.62 | 17.50B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2022-07-18 | 개시 | H.C. Wainwright | Buy |
2022-05-02 | 개시 | Canaccord Genuity | Buy |
2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients - Investing News Network
Clene (CLNN) Highlights Encouraging REPAIR-MS Results at Major M - GuruFocus
Clene (CLNN) Analyst Rating Update: Buy Rating Maintained | CLNN Stock News - GuruFocus
8.65% Brain Energy Metabolism Improvement: Clene's CNM-Au8 Shows Promise in Multiple Sclerosis Treatment Trial - Stock Titan
Is this a good reentry point in Clene Inc. Equity WarrantWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
Clene Inc. (NASDAQ:CLNN) Receives $32.60 Average Price Target from Analysts - MarketBeat
Is Clene Inc. a candidate for recovery playJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Is Clene Inc. Equity Warrant stock ready for a breakoutJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Is Clene Inc. Equity Warrant reversing from oversold territoryQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com
Does Clene Inc. Equity Warrant fit your quant trading modelChart Signals & Weekly High Return Stock Opportunities - newser.com
Price action breakdown for Clene Inc.Market Growth Review & Capital Protection Trade Alerts - newser.com
| MarketBeat - MarketBeat
Multi asset correlation models including Clene Inc.Weekly Trade Analysis & Real-Time Sentiment Analysis - newser.com
Exit strategy if you’re trapped in Clene Inc.Trade Volume Summary & Weekly Stock Breakout Alerts - newser.com
What technical models suggest about Clene Inc.’s comeback2025 Performance Recap & Detailed Earnings Play Strategies - newser.com
Is Clene Inc. still worth holding after the dipStop Loss & Real-Time Volume Surge Alerts - newser.com
Long term hold vs stop loss in Clene Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
Tools to monitor Clene Inc. recovery probabilityWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Risk Recap: Is Clene Inc in a consolidation phaseJuly 2025 Momentum & Fast Moving Market Watchlists - خودرو بانک
What does recent volatility data suggest for Clene Inc. Equity WarrantTreasury Yields & AI Forecasted Stock Moves - newser.com
Using data filters to optimize entry into Clene Inc.Weekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Nanotechnology Stocks To Keep An Eye On – September 18th - Defense World
Performance Recap: Can Clene Inc reach resistance levels soonMarket Risk Analysis & Free Risk Controlled Daily Trade Plans - khodrobank.com
Identifying reversal signals in Clene Inc.Weekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Measuring Clene Inc.’s beta against major indicesJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
Best data tools to analyze Clene Inc. Equity Warrant stockTreasury Yields & Real-Time Volume Triggers - newser.com
What MACD signals say about Clene Inc.2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com
Death Cross: What is the cash position of Clene Inc Equity WarrantEarnings Summary Report & Daily Profit Focused Stock Screening - khodrobank.com
Breakout Move: Will Clene Inc. Equity Warrant outperform during market rallies2025 Macro Impact & Verified Trade Idea Suggestions - خودرو بانک
Pattern recognition hints at Clene Inc. upsideWeekly Trend Recap & Technical Confirmation Alerts - newser.com
Macro Review: What is the Moat Score of Sony Group Corporation Depositary ReceiptJuly 2025 Snapshot & Stock Portfolio Risk Management - khodrobank.com
Earnings Recap: Should I buy Clene Inc Equity Warrant stock nowJuly 2025 Reactions & Reliable Momentum Entry Alerts - khodrobank.com
Building trade automation scripts for Clene Inc. Equity Warrant2025 Price Targets & Advanced Swing Trade Entry Alerts - newser.com
Sentiment Recap: Can Clene Inc. Equity Warrant keep up with sector leadersCEO Change & Technical Entry and Exit Alerts - khodrobank.com
How to use Fibonacci retracement on Clene Inc. Equity WarrantPortfolio Performance Summary & Step-by-Step Swing Trade Plans - newser.com
Clene Inc. stock momentum explainedJuly 2025 Retail & Technical Confirmation Trade Alerts - newser.com
Breakout Move: Will Clene Inc stock benefit from M A2025 Momentum Check & Safe Entry Point Identification - khodrobank.com
Bond Watch: Can Clene Inc grow without external fundingJuly 2025 Big Picture & Weekly Setup with High ROI Potential - خودرو بانک
What machine learning models say about Clene Inc. Equity WarrantJuly 2025 Technicals & Daily Entry Point Alerts - newser.com
Key metrics from Clene Inc. Equity Warrant’s quarterly dataJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
Best Nanotechnology Stocks To Follow NowSeptember 16th - MarketBeat
Clene’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise In Improving Cellular Health In Parkinson’s Disease - Barchart.com
Clene’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise in Improving Cellular Health in Parkinson’s Disease - The Globe and Mail
Full technical analysis of Clene Inc. stockJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Published on: 2025-09-17 06:02:12 - newser.com
How to integrate Clene Inc. Equity Warrant into portfolio analysis toolsEarnings Summary Report & Daily Momentum Trading Reports - newser.com
Aug Reactions: Will Clene Inc. Equity Warrant benefit from government policyMarket Activity Report & Reliable Trade Execution Plans - خودرو بانک
Clene’s CNM-Au8 Shows Promise in Addressing Cellular Deficits in Parkinson’s Disease - citybuzz -
Nanotechnology Stocks Worth WatchingSeptember 14th - MarketBeat
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clene Inc 주식 (CLNN) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
General Resonance LLC | 10% Owner |
Jun 04 '25 |
Sale |
4.04 |
600 |
2,424 |
707,992 |
General Resonance LLC | 10% Owner |
Jun 02 '25 |
Sale |
4.12 |
600 |
2,473 |
708,592 |
General Resonance LLC | 10% Owner |
May 30 '25 |
Sale |
2.80 |
410 |
1,148 |
709,192 |
General Resonance LLC | 10% Owner |
May 29 '25 |
Sale |
2.73 |
410 |
1,119 |
709,602 |
General Resonance LLC | 10% Owner |
May 28 '25 |
Sale |
2.60 |
420 |
1,090 |
710,012 |
General Resonance LLC | 10% Owner |
May 27 '25 |
Sale |
2.45 |
420 |
1,029 |
710,432 |
General Resonance LLC | 10% Owner |
Mar 19 '25 |
Sale |
4.40 |
1,400 |
6,160 |
710,852 |
General Resonance LLC | 10% Owner |
Mar 18 '25 |
Sale |
4.45 |
1,333 |
5,932 |
712,252 |
MATLIN DAVID J | Director |
Sep 30 '24 |
Buy |
4.75 |
92,307 |
438,458 |
444,491 |
Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
자본화:
|
볼륨(24시간):